Accuronix Therapeutics is a biotech company that is applying a novel drug-targeting technology to some of the most difficult problems in cancer therapy.

For more information, visit Accuronix Therapeutics or follow their updates on:

Locations

Financials

  • $625k

Accuronix Therapeutics Articles

Applied Particle Technology

6 WashU faculty-founded startups show velocity for university business creation

mm
Tanya Yatzeck
3 Min Read

Loading

-
300
Visitors

BioGenerator Company Accuronix Targets Pancreatic Cancer

mm
Mary Mack
5 Min Read

Loading

-
255
Visitors